Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News | Stroke

March 14, 2022 – Stroke is an acute disease of the brain and the most common cause of permanent disability in adults in ...

Home March 11, 2022
Home
News | Remote Monitoring

March 13, 2022 – Philips has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a first ...

Home March 11, 2022
Home
News | Coronavirus (COVID-19)

March 13, 2022 – People with a congenital heart defect who were hospitalized with COVID-19 infection were at higher risk ...

Home March 11, 2022
Home
News | Atrial Fibrillation

March 9, 2022 – Point-of-care screening for atrial fibrillation (A-fib) using a new generation of handheld electrocardio ...

Home March 09, 2022
Home
News | Atrial Fibrillation

February 16, 2022 – A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart ...

Home February 16, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 14, 2022 — Philips, a global leader in health technology, is supporting the American Heart Association’s multi ...

Home February 14, 2022
Home
News | Catheters
February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has ...
Home February 09, 2022
Home
News | Cardiovascular Clinical Studies
February 8, 2022  A new study is the first to show that a remote cognitive assessment could help with tracking patients ...
Home February 07, 2022
Home
News | EP Lab

January 14, 2022 — Medtronic has entered into a definitive agreement to acquire Affera Inc., a Boston area-based ...

Home January 14, 2022
Home
News | EP Lab

January 5, 2022 — Stereotaxis announced a recent publication in Frontiers in Cardiovascular Medicine titled “Atrial ...

Home January 05, 2022
Home
Patient applying a Cardiac Insight Cardea SOLO monitoring device at home. The remote, physician-prescribed and patient self-applied device is worn for a specified period of monitoring time and then returned to the physician office for report creation. 
Feature | Atrial Fibrillation

Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...

Home December 07, 2021
Home
News | EP Lab

November 22, 2021 — BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical ...

Home November 22, 2021
Home
News | Atrial Fibrillation

November 17, 2021 — People with atrial fibrillation (AFib) who underwent individualized testing to discover triggers for ...

Home November 17, 2021
Home
News | EP Lab

November 16, 2021 — Acutus Medical Inc. (Acutus), an arrhythmia management company focused on improving the way cardiac ...

Home November 16, 2021
Home
Subscribe Now